- Home
- CWCO vs MGTX Comparison
CWCO vs MGTX Comparison
Compare CWCO & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWCO
- MGTX
- Stock Information
- Founded
- CWCO 1973
- MGTX 2015
- Country
- CWCO Cayman Islands
- MGTX United States
- Employees
- CWCO N/A
- MGTX N/A
- Industry
- CWCO Water Supply
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CWCO Utilities
- MGTX Health Care
- Exchange
- CWCO Nasdaq
- MGTX Nasdaq
- Market Cap
- CWCO 402.4M
- MGTX 479.9M
- IPO Year
- CWCO N/A
- MGTX N/A
- Fundamental
- Price
- CWCO $27.53
- MGTX $7.30
- Analyst Decision
- CWCO
- MGTX Strong Buy
- Analyst Count
- CWCO 0
- MGTX 2
- Target Price
- CWCO N/A
- MGTX $23.50
- AVG Volume (30 Days)
- CWCO 71.3K
- MGTX 278.8K
- Earning Date
- CWCO 03-26-2025
- MGTX 03-13-2025
- Dividend Yield
- CWCO 1.60%
- MGTX N/A
- EPS Growth
- CWCO 71.40
- MGTX N/A
- EPS
- CWCO 2.31
- MGTX N/A
- Revenue
- CWCO $158,810,010.00
- MGTX $13,929,000.00
- Revenue This Year
- CWCO N/A
- MGTX N/A
- Revenue Next Year
- CWCO $8.67
- MGTX $1,391.84
- P/E Ratio
- CWCO $16.57
- MGTX N/A
- Revenue Growth
- CWCO 2.20
- MGTX 108.24
- 52 Week Low
- CWCO $23.55
- MGTX $3.85
- 52 Week High
- CWCO $33.34
- MGTX $7.80
- Technical
- Relative Strength Index (RSI)
- CWCO 59.85
- MGTX 66.58
- Support Level
- CWCO $27.00
- MGTX $6.72
- Resistance Level
- CWCO $28.42
- MGTX $7.06
- Average True Range (ATR)
- CWCO 0.66
- MGTX 0.37
- MACD
- CWCO 0.08
- MGTX 0.05
- Stochastic Oscillator
- CWCO 67.40
- MGTX 71.61
About CWCO Consolidated Water Co. Ltd.
Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties, and The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal and industrial water production, supply and treatment.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.